RU2207113C2 - Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori - Google Patents

Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori Download PDF

Info

Publication number
RU2207113C2
RU2207113C2 RU2000126759/14A RU2000126759A RU2207113C2 RU 2207113 C2 RU2207113 C2 RU 2207113C2 RU 2000126759/14 A RU2000126759/14 A RU 2000126759/14A RU 2000126759 A RU2000126759 A RU 2000126759A RU 2207113 C2 RU2207113 C2 RU 2207113C2
Authority
RU
Russia
Prior art keywords
liposomes
lectins
composition
pylori
composition according
Prior art date
Application number
RU2000126759/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2000126759A (ru
Inventor
Амарджит СИНГХ (IN)
Амарджит Сингх
Раджеш ДЖЕЙН (IN)
Раджеш Джейн
Original Assignee
Панацея Биотек Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Панацея Биотек Лимитед filed Critical Панацея Биотек Лимитед
Publication of RU2000126759A publication Critical patent/RU2000126759A/ru
Application granted granted Critical
Publication of RU2207113C2 publication Critical patent/RU2207113C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2000126759/14A 1999-01-25 2000-01-24 Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori RU2207113C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN141/DEL/99 1999-01-25
IN141DE1999 IN190017B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1999-01-25 1999-01-25

Publications (2)

Publication Number Publication Date
RU2000126759A RU2000126759A (ru) 2002-09-10
RU2207113C2 true RU2207113C2 (ru) 2003-06-27

Family

ID=11088428

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000126759/14A RU2207113C2 (ru) 1999-01-25 2000-01-24 Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori

Country Status (8)

Country Link
US (1) US6306838B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1105097A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2002535266A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU3322100A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0004813A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN190017B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2207113C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2000042987A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2320323C1 (ru) * 2006-08-03 2008-03-27 Игорь Александрович Базиков Система доставки биологически активных веществ с помощью ниосом
RU2378830C2 (ru) * 2003-08-22 2010-01-20 Даниско А/С Инкапсулированный антимикробный материал

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403757A1 (en) * 2000-03-28 2001-10-04 Biochemie Gesellschaft M.B.H. Granulated particles with masked taste
US6576625B2 (en) * 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
EP1350507A1 (en) * 2002-04-04 2003-10-08 Applied NanoSystems B.V. Delivery of a substance to a pre-determinated site
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads
US20070104809A1 (en) 2003-08-22 2007-05-10 Danisco A/S Composition comprising a bacteriocin and an extract from a plant of the labiatae family
US20080206094A1 (en) * 2004-08-11 2008-08-28 Holloway Clifford C Method and Apparatus for Collection and Treatment of Encapsulated Waste
US20180177725A1 (en) * 2015-09-10 2018-06-28 Washington State University Cell membrane-formed nanoscale vesicles and methods of using thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
AU652778B2 (en) * 1990-10-15 1994-09-08 Quest International B.V. Treatment composition
DE69504392T2 (de) 1994-04-07 1999-02-11 Pfizer Inc., New York, N.Y. Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen
GB9407869D0 (en) 1994-04-20 1994-06-15 Caduceus Ltd Antimicrobial compounds
FR2718965B1 (fr) 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle application thérapeutique de la spiramycine.
EP0713392A1 (en) 1994-05-11 1996-05-29 P.N. Gerolymatos S.A. Use of clioquinol for treating helicobacter, including h. pylori, infections and related diseases
GB9505032D0 (en) * 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
EP0820297A4 (en) * 1995-02-07 2002-01-09 Lectin Biopharma Inc METHOD OF USING LECTINS IN THE PREVENTION AND TREATMENT OF ORAL DISORDERS AND DIGESTIVE TUBE
AU5019196A (en) 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2378830C2 (ru) * 2003-08-22 2010-01-20 Даниско А/С Инкапсулированный антимикробный материал
RU2320323C1 (ru) * 2006-08-03 2008-03-27 Игорь Александрович Базиков Система доставки биологически активных веществ с помощью ниосом

Also Published As

Publication number Publication date
JP2002535266A (ja) 2002-10-22
BR0004813A (pt) 2000-11-21
WO2000042987A2 (en) 2000-07-27
AU3322100A (en) 2000-08-07
US6306838B1 (en) 2001-10-23
EP1105097A2 (en) 2001-06-13
WO2000042987A3 (en) 2000-11-02
WO2000042987A8 (en) 2001-06-28
IN190017B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2003-05-31

Similar Documents

Publication Publication Date Title
EP0677295B1 (en) Liposome having oligosaccharide on the surface
KR100317751B1 (ko) 합성미립벡터및그제조방법
KR950013747B1 (ko) 폴리엔 항진균성 항생제를 캡술화한 인지질 입자의 제조 방법 및 이 인지질 입자로 이루어진 제약 조성물
US5612057A (en) Acoustically reflective liposomes and methods to make and use same
Zhang et al. Specific surface modification of liposomes for gut targeting of food bioactive agents
RU2207113C2 (ru) Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori
CN101646462A (zh) 药物转运控制用经肺给药脂质体
WO2005053643A1 (ja) リポソーム
JP5295277B2 (ja) 配糖体含有リポソーム
JP6770524B2 (ja) コクリエート、及び薬理活性物質の組織透過性を高めるためにそれを使用する方法
US6576625B2 (en) Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
AU2006342615B2 (en) Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
JP5057362B2 (ja) リポソーム及びこれを用いた細胞に対する物質注入方法
Ghosh et al. Effect of surface modification with glycolipids and polysaccharides on in vivo fate of liposomes
WO2020254633A1 (en) Liposomal doxorubicin formulation, method for producing a liposomal doxorubicin formulation and use of a liposomal doxorubicin formulation as a medicament
CN1222276C (zh) 阿苯达唑脂质体及中和法制备脂质体方法
CN120114415B (zh) 一种具有腹腔靶向性的氯膦酸盐脂质纳米颗粒及其应用
US20170209605A1 (en) Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
JP3882034B2 (ja) 腸管吸収制御性リポソーム
JP4590519B2 (ja) 腸管吸収制御性リポソーム
AU7897991A (en) Methods for the administration of drugs
JP2007308472A (ja) オリゴ糖を表面に有するリポソームを含むアレルギー治療剤
BR102018069598A2 (pt) formulação lipossomal, composição farmacêutica, uso de uma formulação lipossomal, método para tratamento de câncer, e, processo para preparação de uma formulação lipossomal
WO1992020323A1 (en) Methods for the administration of drugs

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040125